BioCentury | Oct 12, 2018
Finance

A Glympse at drug response

...Oct. 9. Fellow new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital and Inevitable Ventures...
BioCentury | Oct 11, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital and Inevitable Ventures...
BioCentury | Oct 9, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital and Inevitable Ventures...
Items per page:
1 - 3 of 3
BioCentury | Oct 12, 2018
Finance

A Glympse at drug response

...Oct. 9. Fellow new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital and Inevitable Ventures...
BioCentury | Oct 11, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital and Inevitable Ventures...
BioCentury | Oct 9, 2018
Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

...Also participating were new investors Charles River Ventures, Gilead Sciences Inc. (NASDAQ:GILD), Yonghua Capital and Inevitable Ventures...
Items per page:
1 - 3 of 3